Pioneering pulmonary drug delivery
Gilbert Technologies B.V. (Gilbert) is a spin-off of Delft University of Technology (TU Delft) and is based at the High Tech Campus in Eindhoven since 2020. It’s Gilbert’s mission to make medical treatments easier and more effective for lung patients to extend and improve lives, as well as reduce the burden on the healthcare systems.
Years of research work at TU Delft, and later by Gilbert, have been dedicated to the demonstration of proof-of-concept of the electrospray technology and related formulation development for a variety of pharmaceutical compounds. This was successfully done initially on a large benchtop system.
In 2020 Gilbert advanced from the benchtop system to a functional, handheld prototype device. At the same time Gilbert’s team has been preparing the foundation for meeting the stringent requirements for medical devices. This will allow us to seamlessly develop a safe and effective, CE certifiable investigational device for clinical trial developments.
Leveraging the ecosystem
Gilbert draws strength by leveraging the strong ecosystem in the region. Our electrospray technology is based on years of research started at Delft University of Technology and continued at Gilbert.
To advance the technology from the lab to the patient, Gilbert has built an R&D team of seasoned professionals, and along with TU Delft has additionally partnered with Philips Engineering Solutions (PES), its neighbor on the High Tech Campus in Eindhoven and NHL Stenden University of Applied Sciences.
Philips Engineering Solutions
Gilbert is developing the next generation of soft mist inhalers based on proprietary electrospray in partnership with strong collaborators such as Philips.
An experienced and dedicated team
Interested in collaborating with Gilbert?
Board of directors
Non-Executive Director, Chairman of the Board
Non-Executive Director on behalf of DeepTechXL
Non-Executive Director on behalf of NanoCorp
Executive Director, CEO
Scientific advisory board
Prof. Dr. Richard Dekhuijzen
EM. Professor of Pulmonology, University Lung Center Nijmegen, Expert Board ADMIT
Associate Professor, Delft University of Technology
Our mission & vision
It’s our mission to make medical treatment easier and more effective for millions of lung patients to extend and improve lives, while reducing the burden of care on the healthcare systems.
We believe in delivering a social contribution to the well-being of people in general and stimulating healthcare improvements in particular, using the ever evolving technological application-possibilities created by science.
The company-based gathering of scientific findings, in a socially and economically responsible way, will be used for product development for further innovation and optimization of healthcare. With the revenues of this, we will facilitate new scientific research.
Drivers, that are crucial for the development of our devices, are:
in administration of medicines
in terms of comfort, mobility and adherence
applying smart technologies to improve outcomes
ensuring circular products
EHDA technology has the potential to offer unique benefits to patients for aerosolization and medication targeting of advanced molecular entities for respiratory diseases and for pulmonary administration of molecules for other indication areas.
Our core values
Patients are at the heart of everything we do.
We develop through smart application of new and disruptive technologies
We are the trusted company people will turn to for solutions that create a positive impact for patients and society
We are committed to making the world healthier and more sustainable through innovation, while acting responsibly towards the planet and society.
In Q2 2023 Gilbert completed its €7 million Seed – and Series A investment round. The investment rounds were led by Dutch deeptech investor DeepTechXL and joined by existing shareholders NanoCorp and Delft Enterprises. With the transaction also Brabant Startup Fonds has become a shareholder, through conversion of its start-up loan to the company.
The equity financing of €4 million is supplemented by the Netherlands Enterprise Agency (RVO.nl) with an innovation credit of €3 million.
Let’s stay in touch!
Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.